Intensive statin therapy--a sea change in cardiovascular prevention.
about
Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Hypertriglyceridemia: its etiology, effects and treatmentAssessing compliance of cardiologists with the national cholesterol education program (NCEP) III guidelines in an ambulatory care settingPlant sterols: factors affecting their efficacy and safety as functional food ingredientsC-reactive protein (CRP)-lowering agentsBrain cholesterol turnover required for geranylgeraniol production and learning in mice.Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity.Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cellsAtorvastatin inhibits inflammatory hypernociception.The many roles of statins in ischemic strokeHypertriglyceridemia-induced recurrent acute pancreatitis: A case-based review.Statins--a cure-all for the brain?The nurse practitioner's role in helping patients achieve lipid goals with statin therapy.Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.Can intensive statin therapy halt the progression of atherosclerosis? Recent evidence and potential implications for patient management.Dose-dependency in pleiotropic effects of atorvastatin.Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells.The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.Emerging anti-inflammatory drugs for atherosclerosis.Trends in the Use of Evidence-based Therapies Early in the Course of Acute Myocardial Infarction and its Influence on Short Term Patient Outcomes.Genetic basis for developmental toxicity due to statin intake using embryonic stem cell differentiation model.From healthy survivors to sick survivors--implications for the twenty-first century.Complex health problems and mortality among the oldest old in Sweden: decreased risk for men between 1992 and 2002.Statin therapy does not improve lung function in asthma: a meta-analysis of randomized controlled trials.Aggressive lowering of low-density lipoprotein cholesterol: do the studies apply to the elderly?Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus.'Me-Too' Innovation in Pharmaceutical Markets.Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence.A Rare Case of Acute Pancreatitis Due to Very Severe Hypertriglyceridemia (>10 000 mg/dL) Successfully Resolved With Insulin Therapy Alone: A Case Report and Literature Review
P2860
Q24630160-7DE5125E-21A6-4B78-ADA2-46790B0D89EBQ24672914-256B1296-461C-432E-AB31-C2CD3A8CEA74Q24794337-75C986AE-896E-4F27-903E-981ECD80BBC3Q24803635-1F82A890-0F68-4BD7-8804-0E13D97607F7Q28200344-79EA0952-4409-4D18-B86A-36DBB37D088DQ30477204-F8A860F5-27C5-4AFD-BC70-F31531FBDBABQ30586189-59DB3DFD-082E-40C6-BE09-ADD132CD6A7EQ34650855-BC936951-AC01-4966-B64F-9D6DC46F183EQ35119935-6903526E-0BE5-41EC-999C-7437D12A6A04Q35595431-322EE7C6-A77B-4E62-B0F9-B573479B70B5Q35686315-64B0D57D-B694-4F1A-AE6C-E9A4604B800AQ36085649-3B3659DC-3F0B-4BA5-AE6A-692F6FAAE726Q36176396-C6E9B167-34B4-4ADB-B532-33F7CAB0CA31Q36228304-FBD8FD2B-B74D-482D-8247-981DD8A41DCAQ36752063-16C26F39-031A-4A28-AD62-EF80DF8A996EQ37024373-08C900E7-1267-43CE-B176-2A10EFC7ED48Q37321653-3D64A4EA-BA04-4EE3-A902-0F16B35D3E6AQ37332635-CDF83E80-1A9F-4CF1-A4E8-EE7A34191B4AQ38080920-68C0D57C-5C1B-4CAB-9702-33CED8A3F34AQ38106998-7C94FBB9-B302-4F96-B214-E4C249BB9E6AQ38262892-E8BEFF4D-DA8A-47D3-9298-7B91DB534153Q38906383-5CBE6687-A2B7-4781-A3FD-B9CEDABA94B7Q40431362-0DAB1312-1EF2-4A32-A5D5-9791CC36B11BQ41289867-7C6A3EFD-D256-4E8A-9947-5FFB5380F6D4Q44651861-F7D707CF-9DD5-48C2-8052-85FAA807D735Q44990024-B1A5D5D7-BF95-4690-BDDC-4FD1822D5A56Q45925043-A5D7A1ED-7423-4064-856F-5B8CB77419F0Q47136902-97B62F93-4D41-460E-83CD-6A5DC65880A9Q48274225-9CE0D012-9ACF-4F32-8DC1-8F7194087C35Q57841283-1F283B86-B8B7-48F1-A127-7CFF7F2FE958
P2860
Intensive statin therapy--a sea change in cardiovascular prevention.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Intensive statin therapy--a sea change in cardiovascular prevention.
@en
Intensive statin therapy--a sea change in cardiovascular prevention.
@nl
type
label
Intensive statin therapy--a sea change in cardiovascular prevention.
@en
Intensive statin therapy--a sea change in cardiovascular prevention.
@nl
prefLabel
Intensive statin therapy--a sea change in cardiovascular prevention.
@en
Intensive statin therapy--a sea change in cardiovascular prevention.
@nl
P356
P1476
Intensive statin therapy--a sea change in cardiovascular prevention.
@en
P304
P356
10.1056/NEJME048061
P407
P50
P577
2004-03-08T00:00:00Z